0113 343 0933

Translate: Me – The Role of Health Economics in Innovation

date_range Event date: 13/02/18

access_time 09:30 - 16:30

location_on Leeds

Translate_Icons- Innovation

The Role of Health Economics in Innovation

This course aims to raise awareness of the role of health economics in the development of new technologies, and to help researchers understand how health economics can be used at all stages of the innovation pathway. It will also offer opportunities to gain insights into technology development through activities and discussion.

This workshop will cover:

  • The basic principles of health economics
  • The use of health economics in the development of technologies
  • How health economics feeds into the National Institute of Health and Care Excellence (NICE) framework

What you will gain:

A greater understanding of the role of health economics in the development of new health related technologies and in order to promote more efficient innovation.

The workshop will be delivered by Andrew Sutton, David Meads, and Claire Hulme from the Health Economics Unit at the University of Leeds.

Andrew Sutton, Associate Professor in Decision Analytic Modelling. Andrew is a health economist with a particular interest in diagnostics. He specializes in application of model based cost-effectiveness analyses. He is heavily involved in the work of the National Institute for Health Research Diagnostic Evidence Co-operative Leeds (NIHR DEC Leeds) which has been set up to facilitate the research needed to evaluate diagnostic tests, add value to the transit of in-vitro diagnostics (IVDs) through to patient benefits and the commercial market place.

David Meads, Associate Professor. David has over 20 years’ experience in Health Economics and is currently the Module lead for Health Technology Appraisal on the University of Leeds Academic Unit of Health Economics MSc in Health Economics. David conducts cost-effectiveness analyses within clinical trials and decision-modelling for health technology appraisals, in addition to patient preference and health valuation analyses.

Claire Hulme, Professor of Health Economics and Head of the Academic Unit of Health Economics at the University of Leeds. The focus of Claire’s research is economic evaluation alongside clinical trials. She has particular interested in new technologies and was a member of the Medical Technologies Innovation and Knowledge Centre (IKC) Executive Group, University of Leeds from 2011-2015 and National Institute of Health Research Diagnostic Evidence Co-operative Leeds, Methodology Theme Lead for Health Economics between 2015-2015.

All sit on national panels providing health economics input which have, or currently, include the National Institute of Health, Health Technology Appraisal Commissioning Group, NICE Technology Appraisal Committee, NIHR HTA General Board, and the NIHR HTA Elective and Emergency Specialist Care Panel (EESC).

Spaces are limited and registration is essential.

Open to staff and postgraduate research students at Translate partner universities only (Bradford, Huddersfield, Leeds, Leeds Beckett, and York).

Book now to avoid disappointment.


Book now